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410 Letters to the Editorhistory, including a detailed dietary history, is crucial. The
most common route of transmission is ingestion of raw milk
products from diseased animals.
The patient was a shepherd and reported consuming
cheese made from raw milk. He had many acute signs and
symptoms of human brucellosis, i.e., fever, myalgia, anor-
exia, fatigue, sweats and lumbar pain, and other clinical
manifestations such as splenomegaly and hepatomegaly, and
also rare manifestations such as rash and jaundice.
Cutaneous lesions occur in about 5—15% of patients with
brucellosis.2,3 A variety of rarely-reported skin lesions has
been described in brucellosis, including maculopapular
lesions, papules, petechiae, purpura, impetiginous and
psoriform lesions.4 The cutaneous findings observed in
brucellosis are due to direct inoculation, hypersensitivity
phenomena, deposition of immune complexes, and direct
invasion by the organism reaching the skin hematogenously.
Berger et al.2 have separated the cutaneous lesions in
brucellosis into those of exogenous and endogenous char-
acter. Those of exogenous character include brucellar der-
matitis and primary inoculation abscess. Ariza et al.5
divided endogenous cutaneous lesions into four different
groups: disseminated papulonodular eruption, erythema
nodosum-like, extensive purpura, and diffuse maculopap-
ular eruption. Diffuse maculopapular eruption was reported
in three patients in the study of Ariza et al.5 and in one
patient in the study of Ural and Fındık.6
Splenomegaly or hepatomegaly is found in 20 to 30% of
cases. Liver and spleen enlargement with mild nonspecific
elevation of liver enzyme levels can be detected in approxi-
mately 50% of patients with brucellosis.7 The spectrum of
pathologic findings in brucellar hepatitis is varied. Infection
with Brucella abortus is characterized by granulomas. By
contrast, infection with Brucella melitensis produces
lesions ranging from small aggregates of mononuclear cells
surrounding foci of necrosis scattered throughout the par-
enchyma to a diffuse nonspecific inflammation.8
Skin involvement is uncommon in human brucellosis. While
hepatitis is common, it is usually subclinical and jaundice is
rare. This is an unusual case of brucellosis where a patient
showed triple symptoms of fever, jaundice andmaculopapular
rash, and is reported here to remind physicians of the rare
complications of brucellosis; the disease is capable of devel-
oping unexpected complications in unusual organs.Conflict of interest: No conflict of interest to declare.
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In 2000—2001, a measles (rubeola) epidemic occurred
in Korea, with more than 55 000 reported cases.1 During
the outbreak, a total of 16 transplant recipients in our
hemopoietic stem cell transplantation (HSCT) center
were presumptively diagnosed with measles.2 There
have been several reports published on patients who
have developed severe complications after contracting
measles,3—5 most of which refer to children with either
a malignancy or HIV infection. However, measles compli-cations in adults who have received HSCT have rarely been
reported.
A 39-year-old woman was hospitalized for complaints of
diffuse abdominal pain and diarrhea of 3 days’ duration. The
patient had previously been diagnosed to be in the chronic
phase of chronic myelogenous leukemia, and had received an
HLA-matched sibling allogeneic HSCT with busulphan and
cyclophosphamide 15 months prior to this hospitalization.
She was on combined immunosuppressive therapy with
cyclosporin, prednisolone, and mycophenolate mofetil for
extensive chronic graft-versus-host disease (GVHD). There
was no history of a post-HSCT vaccination and no known
recent exposure to measles.
On day 2 of hospitalization she developed a fever, a cough,
and conjunctivitis, which were followed by a maculopapular
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Figure1 Necropsy specimen in rightupper lung:multinucleated
giant cells (arrow)with eosinophilic intranuclear inclusion bodies,
compatible with measles infection, are shown (hematoxylin and
eosin stain, original magnification 400).rash that began on the head and progressed caudally. Koplik’s
spots were observed on the left buccal mucosa. On day 5 the
rash began to resolve, however, the fever persisted. On day 8,
a chest radiograph demonstrated diffuse interstitial infil-
trates throughout the bilateral lung fields. She was treated
with cefoperazone/sulbactam and roxithromycin. Cultures
of blood, sputum, and urine were all repeatedly negative for
bacteria. Serological studies performed on days 2 and 8 did
not demonstrate IgG or IgM antibodies to measles. Cultures of
nasopharyngeal aspirates taken at the same time as the
serological tests were also negative for measles. Assays for
influenza virus, parainfluenza virus, respiratory syncytial
virus (RSV) and adenovirus were all negative. On day 14
the antibiotics were changed to imipenem, vancomycin,
and amphotericin B deoxycholate. Despite the administra-
tion of intravenous immunoglobulin and oxygen, the patient
required endotracheal intubation. She died 22 days after
hospitalization despite aggressive ventilatory support. An
autopsy revealed thickening of alveolar septa and the pre-
sence of multinucleated giant cells with intranuclear eosi-
nophilic inclusions, known as Warthin—Finkeldey giant cells,
which are characteristic of a measles infection (Figure 1).
An atypical course of measles, with respect to the devel-
opment of a rash, has been observed in immunocompromised
patients.3,6 In this case, abdominal pain and diarrhea were
followed by a cough, conjunctivitis, and a rash. The presence
of Koplik’s spots, a rash, a fever and two of the three C signs
(cough, coryza, and conjunctivitis), which were observed in
the patient during the nationwide outbreak, led us to the
diagnosis of measles. Serological tests were of limited diag-
nostic use because of the inability of the patient to mount
adequate antibody responses as a result of her compromised
immunity.5 This inability to mount an adequate antibody
response is one of the reasons why the course of the disease
in this patient was so severe.
The reasons for the higher mortality seen in measles-
related pneumonia include: bacterial superinfection, the
immunosuppressive effects of measles itself, the multisys-
tem involvement of measles, and the severity of the disease
at the time of presentation.7,8 Although co-pathogens were
not identified in this case, bacterial superinfection could
not be excluded.There are anecdotal reports that an MMR vaccination
between 12 and 24 months after HSCT is safe.9,10 Therefore,
in order to prevent measles from being contracted after an
HSCT, especially during an epidemic, the interval to MMR
vaccination following HSCT could potentially be shortened.
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